Economy
Financial Markets
Commodities
Industries
Energy
Real Estate
Local listed Company
Overseas-listed Company
Foreign Company
Industrial Parks


 
Company - Domestic
 Search News  Or
Shanghai Pharma's H1 profit down 14.5%

Aug. 22, 2012 (China Knowledge) - Shanghai Pharmaceuticals Holding Co Ltd<601607><2607>, has announced its net profit for the first half of this year to decrease 14.52% YoY to RMB 1.15 billion, according to a statement filed with Shanghai Stock Exchange.

Basic earnings per share for the six-month period were RMB 0.43, 31.78% lower than in the corresponding period of 2011.

From January to June, the Shanghai and Hong Kong-listed firm's operating revenue surged 30.02% YoY to RMB 33.62 billion.

Revenue from its medicine distribution business grew 34.9% from a year earlier to RMB 28.83 billion in the period, while that from medicine retail business reached RMB 1.32 billion, reflecting a YoY increase of 23.88%.







Add this     
Copyright © "2015" www.chinaknowledge.com

Send feedback or comments to: news@chinaknowledge.com

For more news, financial weekly reports, business guides to China, Market Research Reports and other premium information, subscribe to China Knowledge today

To access our page on Bloomberg, type CKFI (GO)

 Our Professional Services

 E-Store

 News Archive
About Us | CSR | Media Center | E-Newsletter | E-Store | Contact Us | Feedback | Sitemap | Privacy Policy | Terms of Use  

           Copyright © 2014 China Knowledge Online. All Rights Reserved